Alison M Kell (Alison Kell)

Publication Activity (10 Years)

Years Active: 2016-2020
Publications (10 Years): 4

Top Topics

Transcription Factor

Dendritic Cells

Cell Proliferation

Top Venues

The Journal of experimental medicine

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Kirk S Schanze, David G Whitten, Alison M Kell, Eva Y Chi, Linnea K Ista, Florencia A Monge, Pradeepkumar Jagadesan, Virginie Bondu, Patrick L Donabedian
Highly Effective Inactivation of SARS-CoV-2 by Conjugated Polymers and Oligomers. medRxiv : the preprint server for health sciences (2020)
Alison M Kell, Emily A Hemann, J Bryan Turnbull, Michael Gale
RIG-I-like receptor activation drives type I IFN and antiviral signaling to limit Hantaan orthohantavirus replication. PLoS pathogens 16 (4) (2020)
Bhaskar Saha, Devon Chisholm, Alison M Kell, Michael A Mandell
A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α. PLoS pathogens 16 (10) (2020)
MeeAe Hong, Johannes Schwerk, Chrissie Kaishi Lim, Alison M Kell, Abigail Jarret, Joseph Pangallo, Yueh-Ming Loo, Shuanghu Liu, Curt H Hagedorn, Michael Gale, Ram Savan
Interferon lambda 4 expression is suppressed by the host during viral infection. The Journal of experimental medicine 213 (12) (2016)